Assessing quality of life in a clinical study on heart rehabilitation patients: How well do value sets based on given or experienced health states reflect patients' valuations?

Health and Quality of Life Outcomes

Volumn 14, Issue 1, 2016, Pages 1-

  Leidl, Reiner ^a,b   Schweikert, Bernd ^a,c   Hahmann, Harry ^d   Steinacker, Juergen M ^e   Reitmeir, Peter ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAPI GROUP   (Netherlands)

^d Waldburg Zeil Kliniken Klinik Schwabenland   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Decision utility; EQ 5D 3L; Experience based valuation; Patient benefit; Patient reported outcome

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; EQ 5D 3L; EXTERNAL VALIDITY; FEMALE; GERMANY; HEALTH STATUS; HEART REHABILITATION; HOSPITAL PATIENT; HUMAN; MACNEW GLOBAL SCORE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SELF REPORT; VISUAL ANALOG SCALE; ACUTE CORONARY SYNDROME; COMPARATIVE STUDY; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; SWEDEN; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; PATIENT SATISFACTION; QUALITY OF LIFE; REGRESSION ANALYSIS; SELF REPORT; SURVEYS AND QUESTIONNAIRES; SWEDEN;

EID: 84962339401     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-016-0453-3     Document Type: Article

References (27)

1. Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014
2. Knies S, Evers SM, Candel MJ, Severens JL, Ament AJ. Utilities of the EQ-5D: transferable or not? PharmacoEconomics. 2009;27(9):767-79. doi: 10.2165/11314120-000000000-00000.
3. König HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, et al. Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255-61. doi: 10.1097/MLR.0b013e318184759e.
4. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5(1):1-30.
5. Parkin D, Devlin N. Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ. 2006;15(7):653-64. doi: 10.1002/hec.1086.
6. Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12 Suppl 1:S5-9. doi: 10.1111/j.1524-4733.2009.00515.x.
7. Gandjour A. Theoretical foundation of patient v. population preferences in calculating QALYs. Med Decis Making. 2010;30(4):E57-63. doi: 10.1177/0272989x10370488.
8. Burström K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2014;23(2):431-42. doi: 10.1007/s11136-013-0496-4.
9. Leidl R, Reitmeir P. A value set for the EQ-5D based on experienced health states: development and testing for the German population. PharmacoEconomics. 2011;29(6):521-34. doi: 10.2165/11538380-000000000-00000.
10. Sun S, Chen J, Kind P, Xu L, Zhang Y, Burstrom K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2015;24(3):693-703. doi: 10.1007/s11136-014-0793-6.
11. Kiadaliri AA, Gerdtham UG, Eliasson B, Gudbjornsdottir S, Svensson AM, Carlsson KS. Health utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden. Int J Environ Res Public Health. 2014;11(5):4939-52. doi: 10.3390/ijerph110504939.
12. Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2012;21(7):1205-16. doi: 10.1007/s11136-011-0024-3.
13. Gordon M, Greene M, Frumento P, Rolfson O, Garellick G, Stark A. Age- and health-related quality of life after total hip replacement: decreasing gains in patients above 70 years of age. Acta Orthop. 2014;85(3):244-9. doi: 10.3109/17453674.2014.916492.
14. Vogl M, Leidl R, Plotz W, Gutacker N. Comparison of pre- and post-operative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2015;24(2):513-20. doi: 10.1007/s11136-014-0782-9.
15. Leidl R, Reitmeir P, König HH, Stark R. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Value Health. 2012;15(1):151-7. doi: 10.1016/j.jval.2011.08.004.
16. Little M, Reitmeir P, Peters A, Leidl R. Does experience matter when valuing health? A comparison of EQ-5D value tariffs in a German population study. Value Health. 2014;14(4):364-71.
17. Steinacker JM, Liu Y, Muche R, Koenig W, Hahmann H, Imhof A, et al. Long term effects of comprehensive cardiac rehabilitation in an inpatient and outpatient setting. Swiss Med Wkly. 2011;140:w13141. doi: 10.4414/smw.2010.13141.
18. Schweikert B, Hahmann H, Steinacker JM, Imhof A, Muche R, Koenig W, et al. Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation. Clin Res Cardiol. 2009;98(12):787-95. doi: 10.1007/s00392-009-0081-6.
19. Muche R, Imhof A, Studiengruppe S. Das Comprehensive Cohort Design als Alternative zur randomisierten kontrollierten Studie in der Rehabilitationsforschung: Vor- und Nachteile sowie Anwendung in der SARAH-Studie. Rehabilitation. 2003;42(06):343-9. doi: 10.1055/s-2003-45457.
20. EuroQol Group. EQ-5D-3L. 2016. http://www.euroqol.org/eq-5d-products/eq-5d-3l.html. Accessed March 17, 2016.
21. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi: 10.1186/1477-7525-8-13.
22. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart. 2006;92(1):62-7. doi: 10.1136/hrt.2004.052787.
23. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6(2):124-30.
24. Dixon T, Lim LL, Oldridge NB. The MacNew heart disease health-related quality of life instrument: reference data for users. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2002;11(2):173-83.
25. Ruof J, Schwartz FW, Schulenburg JM, Dintsios CM. Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation. Eur J Health Econ. 2014;15(6):577-89. doi: 10.1007/s10198-013-0495-y.
26. Devlin NJ, Tsuchiya A, Buckingham K, Tilling C. A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach. Health Econ. 2011;20(3):348-61. doi: 10.1002/hec.1596.
27. Bernert S, Fernandez A, Haro JM, Konig HH, Alonso J, Vilagut G, et al. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health. 2009;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.